Twenty-nine doctoral, 36 master’s and 154 baccalaureate candidates were eligible to receive degrees in biomedical science fields during the May commencement ceremony.
Jun-Xu Li, MD, PhD, associate professor of pharmacology and toxicology, is being recognized by the American Society for Pharmacology and Experimental Therapeutics (ASPET) with the inaugural JH Woods Early Career Award in Behavioral Pharmacology.
Caroline E. Bass, PhD, assistant professor of pharmacology and toxicology, received a child care award to attend the Federation of European Neuroscience Societies (FENS) Forum in Berlin in July.
New stem cell research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified novel therapeutic targets for the treatment of multiple sclerosis (MS) and other inflammatory diseases.
Nonprescription use of Ritalin may cause irreversible structural changes in certain areas of the brain, according to researchers in the Department of Pharmacology and Toxicology and UB’s Clinical and Research Institute on Addictions (CRIA).
Jennifer A. Martin, a doctoral student in the Department of Pharmacology and Toxicology, has received a prestigious Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience Award from the National Institutes of Health (NIH).
The National Institutes of Health is funding researchers in the Department of Pharmacology and Toxicology to study the effects of drinking, smoking and marijuana use during pregnancy.
Eleven faculty, three emeritus faculty and one staff member from the Jacobs School of Medicine and Biomedical Sciences were among those honored for notable achievement and service at the 15th annual University at Buffalo Celebration of Faculty and Staff Academic Excellence.
A preclinical study conducted by researchers in the Department of Pharmacology and Toxicology has shown for the first time that a class of proteins are important in the neurobiology of relapse or drug-seeking behaviors.
